Gutstein D E, Fuster V
Cardiovascular Institute, Mount Sinai Medical Center, New York, NY 10029-6574, USA.
Cardiovasc Res. 1999 Feb;41(2):323-33. doi: 10.1016/s0008-6363(98)00322-8.
Atherosclerotic plaque rupture and resulting intracoronary thrombosis are thought to account for most acute coronary syndromes. These syndromes include unstable angina, non-Q-wave myocardial infarction (MI) and Q-wave MI. In addition, many cases of sudden cardiac death may be attributable to atherosclerotic plaque disruption and its immediate complications. Our understanding of the atherosclerotic process and the pathophysiology of plaque disruption has advanced remarkably. Despite these advances, event rates after acute coronary syndromes remain unacceptably high. This review will focus on the pathophysiology underlying atherosclerotic plaque development, the sequellae of coronary plaque rupture, and current therapies designed to treat the acute coronary syndromes. It is hoped that as our understanding of the atherosclerotic plaque improves, treatment strategies for the acute coronary syndromes will advance.
动脉粥样硬化斑块破裂及由此导致的冠状动脉内血栓形成被认为是大多数急性冠脉综合征的病因。这些综合征包括不稳定型心绞痛、非Q波心肌梗死(MI)和Q波MI。此外,许多心源性猝死病例可能归因于动脉粥样硬化斑块破裂及其即刻并发症。我们对动脉粥样硬化过程及斑块破裂病理生理学的理解有了显著进展。尽管有这些进展,但急性冠脉综合征后的事件发生率仍然高得令人难以接受。本综述将聚焦于动脉粥样硬化斑块形成的病理生理学、冠状动脉斑块破裂的后果以及旨在治疗急性冠脉综合征的当前疗法。希望随着我们对动脉粥样硬化斑块的理解不断提高,急性冠脉综合征的治疗策略也能取得进展。